Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Role of p53 pathway alterations in uterine carcinosarcomas (malignant mixed Müllerian tumors).

Oncology - 1 Jan 2014

Semczuk Andrzej, Ignatov Atanas, Obrzut Bogdan, Reventos Jaume, Rechberger Tomasz

Abstract excerpt

Carcinosarcomas (CSs; malignant mixed Müllerian tumors) of the uterus are highly malignant neoplasms characterized by an unfavorable outcome. They represent less than 5% of all uterine malignancies, and the median patient survival rate is only 21 months. p53 pathway alterations have been studied in CSs originating from the uterus, supporting the monoclonal nature of most but not all of these neoplasms. This paper...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Biomarkers, Tumor
Share to Mutation
Share to Signal Transduction

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Survival Analysis

Share to Tumor Suppressor Protein p53

Share to Uterine Neoplasms

Source

Identifiers

PMID: 25033979
DOI: 10.1159/000363574

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Role of p53 pathway alterations in uterine carcinosarcomas (malignant mixed Müllerian tumors).PMID 25033979Read ↗

Molecular diversity in uterine carcinosarcoma: Beyond TP53.Semantic proximity Read ↗

Clinicopathologic and Molecular Features of Tubo-Ovarian Carcinosarcomas With an Emphasis on p53 Wild-Type, KRAS-Mutated Tumors.Semantic proximity Read ↗

Carcinosarcomas (malignant mullerian mixed tumors) of the uterus and ovary: a genetic study with special reference to histogenesis.Semantic proximity Read ↗

Uterine carcinosarcoma/malignant mixed Müllerian tumor incidence is increased in women with breast cancer, but independent of hormone therapy.Semantic proximity Read ↗

p53 gene mutation in female genital tract carcinosarcomas (malignant mixed müllerian tumors): a clinicopathologic study of 74 cases.Semantic proximity Read ↗

Special features of sarcomas developed in patients with Lynch syndrome: A systematic review.Semantic proximity Read ↗

Signaling Pathways in Leiomyoma: Understanding Pathobiology and Implications for TherapySemantic proximity Read ↗

Molecular alterations of PIK3CA in uterine carcinosarcoma, clear cell, and serous tumors.Semantic proximity Read ↗

Mesonephric‐like adenocarcinoma of the female genital tract: novel observations and detailed molecular characterisation of mixed tumours and mesonephric‐like carcinosarcomasSemantic proximity Read ↗

Microarray Analysis of Endometrial Carcinomas and Mixed Mullerian Tumors Reveals Distinct Gene Expression Profiles Associated with Different Histologic Types of Uterine CancerSemantic proximity Read ↗

Establishment and characterization of cell lines derived from uterine malignant mixed Müllerian tumor.Semantic proximity Read ↗

p53 protein overexpression and gene mutation in mixed Müllerian tumors of the uterus.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.